Search Within

Jason Earl Chan

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (5)
Groups
  1. Department of Medicine (12)
  2. Department of Pathology and Laboratory Medicine (12)
  3. GSK Faculty (12)
  4. Sarcoma Service (12)
  5. Solid Tumor Oncology Division (12)
  6. Tow Center for Developmental Oncology (TCDO) (11)

More Groups

People
  1. Cristina Antonescu (11)
  2. William Tap (11)
  3. Ciara Kelly (10)
  4. Evan Rosenbaum (10)
  5. Mark Dickson (10)
  6. Mary Keohan (10)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (4)
  4. 2020 (1)
  5. 2019 (1)
Publications
  1. Annals of Oncology (3)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Oncology (2)
  4. Nature Communications (2)
  5. Cancer Cell (1)
  6. Journal for ImmunoTherapy of Cancer (1)

More Publications

Publishers
  1. Oxford University Press (3)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (2)
  4. Nature Publishing Group (2)
  5. Biomed Central Ltd (1)
  6. Cell Press (1)

More Publishers

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
    Meeting Abstract

    Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Utility of circulating tumor DNA (ctDNA) as a molecular biomarker in the phase II trial of imatinib plus binimetinib in patients with treatment-naïve, advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Kelly, C. M.; Bradic, M.; Saunds, S.; Avutu, V.; Chan, J.; D'Angelo, S. P.; Dickson, M.; Gounder, M.; Keohan, M. L.; Movva, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with the PD-1 inhibitor retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M.; Movva, S.; Kelly, C. M.; Chan, J.; Chi, P.; Banks, L.; Keohan, M. L.; Gounder, M.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Do patients with myxofibrosarcoma and undifferentiated pleomorphic sarcoma have different clinical outcomes to immune checkpoint blockade-based therapy?
    Meeting Abstract

    Rosenbaum, E.; Seier, K.; Bradic, M.; Desir, R.; Kelly, C. M.; Movva, S.; Avutu, V.; Banks, L. B.; Chan, J. E.; Chi, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase II study of palbociclib combined with retifanlimab in patients with advanced dedifferentiated liposarcoma
    Meeting Abstract

    D'Angelo, S. P.; Rosenbaum, E.; Gularte Mérida, R.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
    Journal Article

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S. A.; Antonescu, C. R.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N. D.; Rana, S.; Zehir, A.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.; Richards, A. L.; Conley, A. P.; Woo, H. J.; Dickson, M. A.; Gounder, M.; Kelly, C.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
    Journal Article

    Rosenbaum, E.; Antonescu, C. R.; Smith, S.; Bradic, M.; Kashani, D.; Richards, A. L.; Donoghue, M.; Kelly, C. M.; Nacev, B.; Chan, J. E.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save